Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction.
All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People's Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.